PARAMOUNT GOLD NEVADA CORP (PZG)

US69924M1099 - Common Stock

0.435  +0.01 (+1.16%)

After market: 0.46 +0.03 (+5.75%)

Fundamental Rating

1

Overall PZG gets a fundamental rating of 1 out of 10. We evaluated PZG against 157 industry peers in the Metals & Mining industry. PZG has a bad profitability rating. Also its financial health evaluation is rather negative. PZG is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year PZG has reported negative net income.
PZG had a negative operating cash flow in the past year.
In the past 5 years PZG always reported negative net income.
PZG had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PZG has a Return On Assets of -11.67%. This is in the lower half of the industry: PZG underperforms 73.89% of its industry peers.
PZG has a Return On Equity of -17.67%. This is in the lower half of the industry: PZG underperforms 70.06% of its industry peers.
Industry RankSector Rank
ROA -11.67%
ROE -17.67%
ROIC N/A
ROA(3y)-12.27%
ROA(5y)-12.17%
ROE(3y)-14.8%
ROE(5y)-14.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 74.48%, PZG belongs to the best of the industry, outperforming 98.09% of the companies in the same industry.
PZG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

PZG does not have a ROIC to compare to the WACC, probably because it is not profitable.
PZG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PZG has been increased compared to 5 years ago.
The debt/assets ratio for PZG is higher compared to a year ago.

2.2 Solvency

PZG has an Altman-Z score of -1.26. This is a bad value and indicates that PZG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.26, PZG is doing worse than 83.44% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that PZG is not too dependend on debt financing.
PZG's Debt to Equity ratio of 0.37 is on the low side compared to the rest of the industry. PZG is outperformed by 69.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -1.26
ROIC/WACCN/A
WACC8.15%

2.3 Liquidity

PZG has a Current Ratio of 2.20. This indicates that PZG is financially healthy and has no problem in meeting its short term obligations.
PZG has a Current ratio (2.20) which is comparable to the rest of the industry.
A Quick Ratio of 2.20 indicates that PZG has no problem at all paying its short term obligations.
The Quick ratio of PZG (2.20) is better than 62.42% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

1

3. Growth

3.1 Past

PZG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.54%, which is quite good.
Looking at the last year, PZG shows a very strong growth in Revenue. The Revenue has grown by 2385.47%.
PZG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.94% yearly.
EPS 1Y (TTM)9.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)2385.47%
Revenue growth 3Y-37.29%
Revenue growth 5Y-11.94%
Sales Q2Q%2076.68%

3.2 Future

PZG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -54.11% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-75%
EPS Next 2Y-54.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

PZG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PZG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PZG's earnings are expected to decrease with -54.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PZG!.
Industry RankSector Rank
Dividend Yield N/A

PARAMOUNT GOLD NEVADA CORP

NYSEARCA:PZG (7/26/2024, 7:04:01 PM)

After market: 0.46 +0.03 (+5.75%)

0.435

+0.01 (+1.16%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap27.68M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.67%
ROE -17.67%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 74.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)9.54%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2385.47%
Revenue growth 3Y-37.29%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y